Trinean Licenses Microfluidic IP from PerkinElmer's Caliper Business | GenomeWeb

NEW YORK (GenomeWeb News) – Belgian spectrophotometer firm Trinean today said it has licensed intellectual property covering microfluidic technologies from PerkinElmer's Caliper Life Sciences business directed at UV-VIS quantification analysis.

The license allows Trinean to design and develop microfluidic cartridges and instruments for the UV/VIS quantification of light-absorbing substances for certain life science applications, Trinean said. Further details of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.